scholarly journals Advanced Treatment and Imaging in Colonoscopy: The Pocket-Creation Method for Complete Resection and Linked Color Imaging for Better Detection of Early Neoplastic Lesions by Colonoscopy

2019 ◽  
Vol 52 (2) ◽  
pp. 107-113 ◽  
Author(s):  
Hironori Yamamoto ◽  
Satoshi Shinozaki ◽  
Yoshikazu Hayashi ◽  
Yoshimasa Miura ◽  
Tsevelnorov Khurelbaatar ◽  
...  
2018 ◽  
Vol 50 (2) ◽  
pp. e147
Author(s):  
G. Mogavero ◽  
S. Paggi ◽  
A. Amato ◽  
A. Andrealli ◽  
G. Imperiali ◽  
...  

Endoscopy ◽  
2018 ◽  
Vol 50 (04) ◽  
pp. 396-402 ◽  
Author(s):  
Silvia Paggi ◽  
Giuseppe Mogavero ◽  
Arnaldo Amato ◽  
Emanuele Rondonotti ◽  
Alida Andrealli ◽  
...  

Abstract Background Linked color imaging (LCI) is a newly developed image-enhancing endoscopy technology that provides bright endoscopic images and increases color contrast. We investigated whether LCI improves the detection of neoplastic lesions in the right colon when compared with high definition white-light imaging (WLI). Methods Consecutive patients undergoing colonoscopy were randomized (1:1) after cecal intubation into right colon inspection at first pass by LCI or by WLI. At the hepatic flexure, the scope was reintroduced to the cecum under LCI and a second right colon inspection was performed under WLI in previously LCI-scoped patients (LCI–WLI group) and vice versa (WLI–LCI group). Lesions detected on first- and second-pass examinations were used to calculate detection and miss rates, respectively. The primary outcome was the right colon adenoma miss rate. Results Of the 600 patients enrolled, 142 had at least one adenoma in the right colon, with similar right colon adenoma detection rates (r-ADR) in the two groups (22.7 % in LCI–WLI and 24.7 % in WLI–LCI). At per-polyp analysis, double inspection of the right colon in the LCI–WLI and WLI–LCI groups resulted in an 11.8 % and 30.6 % adenoma miss rate, respectively (P < 0.001). No significant difference in miss rate was found for advanced adenomas or sessile serrated lesions. At per-patient analysis, at least one adenoma was identified in the second pass only (incremental ADR) in 2 of 300 patients (0.7 %) in the LCI – WLI group and in 13 of 300 patients (4.3 %) in the WLI – LCI group (P = 0.01). Conclusions LCI could reduce the miss rate of neoplastic lesions in the right colon.


2018 ◽  
Vol 87 (6) ◽  
pp. AB236
Author(s):  
Silvia Paggi ◽  
Giuseppe Mogavero ◽  
Arnaldo Amato ◽  
Alida Andrealli ◽  
Gianni Imperiali ◽  
...  

2022 ◽  
Vol 10 (01) ◽  
pp. E88-E95
Author(s):  
Ken Haruma ◽  
Mototsugu Kato ◽  
Kenro Kawada ◽  
Takahisa Murao ◽  
Shoko Ono ◽  
...  

Abstract Background and study aims Linked color imaging (LCI) is a new image-enhancing technique that facilitates the differentiation of slight differences in mucosal color tone. We performed an exploratory analysis to evaluate the diagnostic capability of LCI in ultraslim endoscopy, using data from patients examined in the LCI-Further Improving Neoplasm Detection in upper gastrointestinal (LCI-FIND) trial, a large-scale, multicenter, randomized controlled trial that demonstrated the capability of LCI for detecting neoplastic lesions in the upper gastrointestinal tract. Patients and methods Data from the LCI-FIND prospective trial were used. In the LCI-FIND trial, 1502 patients with a history of gastrointestinal cancer were randomly assigned to two groups based on examination methods: white light imaging (WLI) followed by LCI (WLI group) and LCI followed by WLI (LCI group). The present exploratory analysis investigated the outcomes of patients who underwent ultraslim and standard endoscopies. Results Ultraslim endoscopes were used in 223 patients and standard endoscopes in 1279 patients. The primary endpoint of the LCI-FIND trial was the percentage of patients diagnosed with a neoplastic lesion using WLI or LCI. The corresponding percentage tended to be higher with LCI than with WLI among patients who underwent ultraslim endoscopy and among those who underwent standard endoscopy; the crude risk ratio was 2.21 [95 % confidence interval (CI): 1.06–4.67], and the adjusted odds ratio was 2.46 (95 % CI: 1.07–5.63). Conclusions Our exploratory analysis of data from the LCI-FIND trial showed that LCI is useful in identifying neoplastic lesions, when used in ultraslim endoscopy.


Sign in / Sign up

Export Citation Format

Share Document